THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE

THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE was reported 30745 times

These side effects are most commonly reported by patients taking THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE:

# Side effect Count
0 FATIGUE 3459
1 NAUSEA 2299
2 DIARRHOEA 2267
3 HEADACHE 2175
4 PAIN 1829
5 DRUG INEFFECTIVE 1720
6 DIZZINESS 1719
7 DYSPNOEA 1571
8 ARTHRALGIA 1503
9 ASTHENIA 1423
10 OFF LABEL USE 1352
11 FALL 1317
12 WEIGHT DECREASED 1118
13 INSOMNIA 1105
14 PAIN IN EXTREMITY 1100
15 VOMITING 1076
16 RASH 1073
17 MALAISE 1040
18 ANXIETY 1027
19 PRURITUS 1025
20 COUGH 1016
21 PNEUMONIA 971
22 CONSTIPATION 922
23 GAIT DISTURBANCE 911
24 BACK PAIN 901
25 DEATH 899
26 MUSCLE SPASMS 871
27 DECREASED APPETITE 869
28 DEPRESSION 862
29 SOMNOLENCE 857
30 PRODUCT DOSE OMISSION ISSUE 815
31 NASOPHARYNGITIS 811
32 FEELING ABNORMAL 797
33 PYREXIA 797
34 URINARY TRACT INFECTION 788
35 WEIGHT INCREASED 767
36 PERIPHERAL SWELLING 764
37 CONDITION AGGRAVATED 747
38 ALOPECIA 697
39 HYPOAESTHESIA 696
40 ABDOMINAL DISCOMFORT 694
41 HYPERTENSION 668
42 ABDOMINAL PAIN UPPER 666
43 NEUROPATHY PERIPHERAL 635
44 PARAESTHESIA 626
45 ABDOMINAL PAIN 596
46 MEMORY IMPAIRMENT 595
47 SINUSITIS 595
48 COVID-19 587
49 GASTROOESOPHAGEAL REFLUX DISEASE 578
50 BLOOD PRESSURE INCREASED 568
51 MYALGIA 567
52 MUSCULAR WEAKNESS 561
53 CHEST PAIN 541
54 CONFUSIONAL STATE 521
55 BALANCE DISORDER 520
56 TREMOR 516
57 HYPOTENSION 498
58 ANAEMIA 497
59 DRUG HYPERSENSITIVITY 475
60 CONTUSION 473
61 HYPERSENSITIVITY 462
62 WHITE BLOOD CELL COUNT DECREASED 457
63 INFECTION 455
64 VISION BLURRED 444
65 JOINT SWELLING 439
66 MIGRAINE 430
67 MUSCULOSKELETAL STIFFNESS 429
68 DYSPEPSIA 426
69 INJECTION SITE PAIN 416
70 CHILLS 412
71 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 411
72 DEHYDRATION 405
73 PRODUCT USE IN UNAPPROVED INDICATION 398
74 RHEUMATOID ARTHRITIS 397
75 URTICARIA 393
76 BRONCHITIS 391
77 HAEMOGLOBIN DECREASED 388
78 DRY MOUTH 387
79 INFLUENZA 385
80 PRODUCT USE ISSUE 385
81 ERYTHEMA 378
82 OEDEMA PERIPHERAL 372
83 PALPITATIONS 370
84 ABDOMINAL DISTENSION 364
85 VISUAL IMPAIRMENT 364
86 ATRIAL FIBRILLATION 363
87 OROPHARYNGEAL PAIN 358
88 DRY SKIN 352
89 HOT FLUSH 351
90 ILLNESS 341
91 PLATELET COUNT DECREASED 339
92 FLUSHING 338
93 HYPERHIDROSIS 329
94 SLEEP DISORDER 325
95 CHEST DISCOMFORT 322
96 BLOOD GLUCOSE INCREASED 320
97 ARTHRITIS 318
98 HEART RATE INCREASED 318
99 GASTROINTESTINAL DISORDER 316
100 SWELLING 316
101 ASTHMA 313
102 STOMATITIS 309
103 MULTIPLE SCLEROSIS RELAPSE 305
104 LOSS OF CONSCIOUSNESS 303
105 EYE PAIN 297
106 DRUG DOSE OMISSION 293
107 RHINORRHOEA 291
108 STRESS 290
109 ACUTE KIDNEY INJURY 289
110 MOBILITY DECREASED 287
111 CHRONIC KIDNEY DISEASE 282
112 SEPSIS 280
113 AMNESIA 279
114 INCORRECT DOSE ADMINISTERED 277
115 DYSPHAGIA 276
116 GENERAL PHYSICAL HEALTH DETERIORATION 276
117 HALLUCINATION 269
118 NECK PAIN 263
119 PNEUMONIA ASPIRATION 262
120 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 262
121 INTENTIONAL PRODUCT USE ISSUE 261
122 FLATULENCE 260
123 PSORIASIS 257
124 UPPER RESPIRATORY TRACT INFECTION 257
125 DISCOMFORT 256
126 RENAL FAILURE 256
127 COMA 255
128 DRUG INTOLERANCE 253
129 MUSCULOSKELETAL PAIN 251
130 BONE PAIN 247
131 SEIZURE 247
132 ARTHROPATHY 246
133 SYNCOPE 245
134 CEREBROVASCULAR ACCIDENT 244
135 OSTEOARTHRITIS 244
136 INFUSION RELATED REACTION 243
137 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 243
138 THROMBOSIS 240
139 HOSPITALISATION 239
140 DYSPHONIA 238
141 OXYGEN SATURATION DECREASED 238
142 SUICIDAL IDEATION 238
143 OEDEMA 235
144 UNEVALUABLE EVENT 235
145 EPISTAXIS 234
146 HEPATIC ENZYME INCREASED 234
147 PRODUCTIVE COUGH 231
148 BLOOD CHOLESTEROL INCREASED 227
149 DISEASE PROGRESSION 226
150 DRUG INTERACTION 225
151 BURNING SENSATION 223
152 BLOOD PRESSURE DECREASED 220
153 NASAL CONGESTION 216
154 INFLUENZA LIKE ILLNESS 215
155 FLUID RETENTION 213
156 DRY EYE 211
157 PRODUCT SUBSTITUTION ISSUE 209
158 BLISTER 208
159 ADVERSE DRUG REACTION 207
160 NIGHT SWEATS 205
161 HERPES ZOSTER 202
162 TACHYCARDIA 199
163 POLLAKIURIA 196
164 OSTEOPOROSIS 195
165 RED BLOOD CELL COUNT DECREASED 194
166 THERAPY CESSATION 194
167 LUNG DISORDER 193
168 CATARACT 192
169 THERAPY INTERRUPTED 192
170 TINNITUS 192
171 CELLULITIS 191
172 INFLAMMATION 191
173 FIBROMYALGIA 189
174 GAIT INABILITY 189
175 NEUTROPENIA 188
176 COGNITIVE DISORDER 186
177 MYOCARDIAL INFARCTION 186
178 WHEEZING 185
179 HEAD INJURY 184
180 PSORIATIC ARTHROPATHY 184
181 BLOOD CREATININE INCREASED 183
182 CARDIAC DISORDER 183
183 FEELING HOT 183
184 THERAPEUTIC RESPONSE UNEXPECTED 183
185 CARDIAC FAILURE CONGESTIVE 182
186 HAEMORRHAGE 181
187 VERTIGO 180
188 INJECTION SITE ERYTHEMA 179
189 LETHARGY 179
190 MULTIPLE SCLEROSIS 179
191 DYSGEUSIA 177
192 INJURY 176
193 EYE IRRITATION 173
194 ROAD TRAFFIC ACCIDENT 173
195 IMPAIRED HEALING 172
196 SEASONAL ALLERGY 171
197 LOWER RESPIRATORY TRACT INFECTION 168
198 PULMONARY EMBOLISM 168
199 SLEEP APNOEA SYNDROME 168
200 NEPHROLITHIASIS 167
201 THROMBOCYTOPENIA 167
202 INJECTION SITE BRUISING 166
203 SURGERY 165
204 DEPRESSED MOOD 164
205 INTENTIONAL PRODUCT MISUSE 163
206 DYSPNOEA EXERTIONAL 161
207 FULL BLOOD COUNT DECREASED 161
208 SKIN EXFOLIATION 161
209 SYSTEMIC LUPUS ERYTHEMATOSUS 161
210 EAR INFECTION 160
211 GLOSSODYNIA 160
212 NERVOUSNESS 158
213 IRRITABILITY 157
214 SKIN DISCOLOURATION 157
215 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157
216 GASTROINTESTINAL HAEMORRHAGE 156
217 DEVICE ISSUE 155
218 RASH PRURITIC 152
219 LIMB DISCOMFORT 150
220 RENAL IMPAIRMENT 150
221 PLEURAL EFFUSION 148
222 THROAT IRRITATION 148
223 AGITATION 147
224 DISTURBANCE IN ATTENTION 147
225 NEURALGIA 147
226 RENAL DISORDER 147
227 WOUND 147
228 PRODUCT QUALITY ISSUE 146
229 DYSARTHRIA 145
230 SWELLING FACE 142
231 THERAPEUTIC RESPONSE DECREASED 142
232 UNDERDOSE 142
233 HEART RATE DECREASED 141
234 PLASMA CELL MYELOMA 141
235 THERAPEUTIC PRODUCT EFFECT DECREASED 141
236 IRRITABLE BOWEL SYNDROME 139
237 JOINT STIFFNESS 139
238 BLOOD PRESSURE FLUCTUATION 138
239 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 138
240 SPEECH DISORDER 138
241 CYSTITIS 137
242 EAR PAIN 137
243 INJECTION SITE PRURITUS 137
244 HYPONATRAEMIA 136
245 ILL-DEFINED DISORDER 135
246 LOWER LIMB FRACTURE 135
247 ADVERSE EVENT 133
248 DYSKINESIA 133
249 BLOOD POTASSIUM DECREASED 132
250 FUNGAL INFECTION 131
251 MUSCLE SPASTICITY 131
252 SCIATICA 130
253 DEEP VEIN THROMBOSIS 129
254 PRODUCT DOSE OMISSION 129
255 URINARY INCONTINENCE 129
256 LIMB INJURY 128
257 MOVEMENT DISORDER 127
258 VIRAL INFECTION 126
259 CROHN^S DISEASE 125
260 MATERNAL EXPOSURE DURING PREGNANCY 125
261 HYPERSOMNIA 123
262 INJECTION SITE SWELLING 123
263 OCULAR HYPERAEMIA 123
264 PANIC ATTACK 123
265 PULMONARY FIBROSIS 123
266 LIVER DISORDER 122
267 NOCTURIA 122
268 DELIRIUM 121
269 MALIGNANT NEOPLASM PROGRESSION 121
270 OBESITY 121
271 TYPE 2 DIABETES MELLITUS 121
272 DIABETES MELLITUS 120
273 DYSSTASIA 120
274 WHITE BLOOD CELL COUNT INCREASED 120
275 EMOTIONAL DISTRESS 117
276 PRESCRIBED UNDERDOSE 117
277 THERAPY NON-RESPONDER 117
278 ORAL PAIN 116
279 RASH ERYTHEMATOUS 116
280 TASTE DISORDER 116
281 HAEMATOCHEZIA 115
282 BURSITIS 114
283 LIVER INJURY 114
284 PEMPHIGUS 114
285 POOR QUALITY SLEEP 114
286 BRAIN FOG 113
287 DYSURIA 113
288 OVERDOSE 113
289 SINUS DISORDER 113
290 TOOTH DISORDER 113
291 BRADYCARDIA 111
292 LACRIMATION INCREASED 111
293 SYNOVITIS 111
294 KNEE ARTHROPLASTY 110
295 RESPIRATORY DISORDER 110
296 CARDIO-RESPIRATORY ARREST 109
297 EYE PRURITUS 109
298 EYE SWELLING 109
299 JOINT RANGE OF MOTION DECREASED 108
300 DISORIENTATION 107
301 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 107
302 LABORATORY TEST ABNORMAL 107
303 RESPIRATORY FAILURE 107
304 ANGER 106
305 PAIN IN JAW 106
306 PULMONARY OEDEMA 106
307 PRE-EXISTING CONDITION IMPROVED 105
308 RHEUMATOID FACTOR POSITIVE 105
309 TREATMENT NONCOMPLIANCE 105
310 LIP DRY 104
311 PERICARDITIS 104
312 AGEUSIA 103
313 INJECTION SITE HAEMORRHAGE 103
314 BACK DISORDER 102
315 HAEMATOCRIT DECREASED 102
316 JOINT INJURY 102
317 HAND DEFORMITY 101
318 LOCALISED INFECTION 101
319 ALANINE AMINOTRANSFERASE INCREASED 100
320 HIP FRACTURE 100
321 CONTRAINDICATED PRODUCT ADMINISTERED 99
322 CRYING 99
323 FEMUR FRACTURE 99
324 HEART RATE IRREGULAR 99
325 HYPOACUSIS 99
326 CHOLELITHIASIS 98
327 FOOT DEFORMITY 98
328 LIVER FUNCTION TEST INCREASED 98
329 WITHDRAWAL SYNDROME 98
330 INTERVERTEBRAL DISC PROTRUSION 97
331 BLOOD PRESSURE SYSTOLIC INCREASED 96
332 EYE DISORDER 96
333 HEAD DISCOMFORT 96
334 LYMPHOCYTE COUNT DECREASED 96
335 HYPOXIA 95
336 LYMPHADENOPATHY 95
337 RASH MACULAR 95
338 RESPIRATORY TRACT INFECTION 95
339 SKIN DISORDER 95
340 BREAST CANCER 94
341 HELICOBACTER INFECTION 94
342 INJECTION SITE REACTION 94
343 NO ADVERSE EVENT 94
344 ACNE 93
345 HYPOPHAGIA 93
346 INTESTINAL OBSTRUCTION 93
347 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 92
348 CARDIAC FAILURE 92
349 FEELING COLD 92
350 GASTRIC DISORDER 92
351 MICTURITION URGENCY 92
352 PRODUCT DOSE OMISSION IN ERROR 92
353 SNEEZING 91
354 CARDIAC ARREST 89
355 DIVERTICULITIS 89
356 MUSCLE INJURY 89
357 PERIPHERAL VENOUS DISEASE 89
358 RESTLESS LEGS SYNDROME 89
359 ARRHYTHMIA 88
360 ASPARTATE AMINOTRANSFERASE INCREASED 88
361 C-REACTIVE PROTEIN ABNORMAL 88
362 MOOD SWINGS 88
363 SKIN LESION 88
364 BLOOD GLUCOSE DECREASED 87
365 ECZEMA 87
366 FREQUENT BOWEL MOVEMENTS 87
367 INFUSION SITE PAIN 87
368 THERAPEUTIC RESPONSE SHORTENED 87
369 URINARY RETENTION 87
370 HYPERCHOLESTEROLAEMIA 86
371 HYPOTHYROIDISM 86
372 LARYNGITIS 86
373 ORAL HERPES 86
374 ACUTE MYOCARDIAL INFARCTION 84
375 AUTOIMMUNE DISORDER 84
376 DUODENAL ULCER PERFORATION 84
377 RESTLESSNESS 84
378 DERMATITIS CONTACT 83
379 FOLLICULITIS 83
380 INSURANCE ISSUE 83
381 MUSCLE TIGHTNESS 83
382 PHOTOPHOBIA 83
383 DIPLOPIA 82
384 DISEASE RECURRENCE 82
385 FEELING JITTERY 82
386 INTENTIONAL DOSE OMISSION 82
387 WOUND INFECTION 82
388 CLOSTRIDIUM DIFFICILE INFECTION 81
389 RIB FRACTURE 81
390 SKIN BURNING SENSATION 81
391 STAPHYLOCOCCAL INFECTION 81
392 APHASIA 80
393 BLINDNESS 80
394 END STAGE RENAL DISEASE 80
395 MUSCLE TWITCHING 80
396 PARKINSON^S DISEASE 80
397 ACCIDENTAL EXPOSURE TO PRODUCT 79
398 DERMATITIS ATOPIC 79
399 GRIP STRENGTH DECREASED 79
400 HEPATIC CIRRHOSIS 79
401 HYPERGLYCAEMIA 79
402 JOINT DISLOCATION 79
403 NEUTROPHIL COUNT DECREASED 79
404 NIGHTMARE 79
405 RESPIRATORY TRACT CONGESTION 79
406 MENTAL DISORDER 78
407 TRANSIENT ISCHAEMIC ATTACK 78
408 DISLOCATION OF VERTEBRA 77
409 EXOSTOSIS 77
410 FACET JOINT SYNDROME 77
411 SPINAL FRACTURE 77
412 CANDIDA INFECTION 76
413 GASTROENTERITIS VIRAL 76
414 HIP ARTHROPLASTY 76
415 HYPOGLYCAEMIA 76
416 SKIN ULCER 76
417 FOOT FRACTURE 75
418 GASTRITIS 75
419 TREATMENT FAILURE 75
420 MUSCULOSKELETAL DISCOMFORT 74
421 SINUS CONGESTION 74
422 BACTERIAL INFECTION 73
423 BODY TEMPERATURE INCREASED 73
424 COLITIS 73
425 ERECTILE DYSFUNCTION 73
426 INCREASED TENDENCY TO BRUISE 73
427 NEOPLASM MALIGNANT 73
428 SWOLLEN TONGUE 73
429 ANKLE FRACTURE 72
430 EATING DISORDER 72
431 HIATUS HERNIA 72
432 KIDNEY INFECTION 72
433 NEOPLASM PROGRESSION 72
434 RED BLOOD CELL SEDIMENTATION RATE INCREASED 72
435 RETCHING 72
436 TOXICITY TO VARIOUS AGENTS 72
437 FEEDING DISORDER 71
438 GLOMERULAR FILTRATION RATE DECREASED 71
439 HYPOKALAEMIA 71
440 MIDDLE INSOMNIA 71
441 MULTIPLE ALLERGIES 71
442 RECTAL HAEMORRHAGE 71
443 WALKING AID USER 71
444 APHONIA 70
445 EMOTIONAL DISORDER 70
446 PLATELET COUNT INCREASED 70
447 PRESCRIBED OVERDOSE 70
448 PRESYNCOPE 70
449 TOOTH INFECTION 70
450 ATAXIA 69
451 BLADDER DISORDER 69
452 C-REACTIVE PROTEIN INCREASED 69
453 FEAR 69
454 HERNIA 69
455 HYPERKALAEMIA 69
456 IMPAIRED WORK ABILITY 69
457 ROTATOR CUFF SYNDROME 69
458 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 68
459 BLOOD PRESSURE ABNORMAL 68
460 BODY HEIGHT DECREASED 68
461 DRUG EFFECT INCOMPLETE 68
462 DRUG WITHDRAWAL SYNDROME 68
463 VITAMIN D DEFICIENCY 68
464 CARPAL TUNNEL SYNDROME 67
465 DEAFNESS 67
466 GOUT 67
467 INJECTION SITE MASS 67
468 MOOD ALTERED 67
469 PANCYTOPENIA 67
470 SEPTIC SHOCK 67
471 ABNORMAL BEHAVIOUR 66
472 BONE DISORDER 66
473 DEMENTIA 66
474 HAEMORRHOIDS 66
475 HEPATIC STEATOSIS 66
476 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 66
477 MUSCULOSKELETAL DISORDER 66
478 PULMONARY MASS 66
479 ACUTE RESPIRATORY FAILURE 65
480 ASCITES 65
481 BLOOD SODIUM DECREASED 65
482 BLOOD IRON DECREASED 64
483 BLOOD POTASSIUM INCREASED 64
484 BLOOD UREA INCREASED 64
485 BONE EROSION 64
486 HALLUCINATION, VISUAL 64
487 PANCREATITIS 64
488 RHEUMATIC FEVER 64
489 SWOLLEN JOINT COUNT INCREASED 64
490 DEVICE MALFUNCTION 63
491 INFUSION SITE ERYTHEMA 63
492 PRODUCT USE COMPLAINT 63
493 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 63
494 CENTRAL NERVOUS SYSTEM LESION 62
495 INCONTINENCE 62
496 MENTAL IMPAIRMENT 62
497 OSTEOPENIA 62
498 SKIN CANCER 62
499 SKIN FISSURES 62
500 ULCER 62
501 WEIGHT FLUCTUATION 62
502 MUSCULOSKELETAL CHEST PAIN 61
503 SKIN HAEMORRHAGE 61
504 BODY TEMPERATURE DECREASED 60
505 BREAST CANCER STAGE II 60
506 COLITIS ULCERATIVE 60
507 DEVICE DISLOCATION 60
508 DIZZINESS POSTURAL 60
509 GLYCOSYLATED HAEMOGLOBIN INCREASED 60
510 HAEMOPTYSIS 60
511 LUPUS-LIKE SYNDROME 60
512 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 60
513 PERIPHERAL COLDNESS 60
514 PRODUCT ADMINISTRATION INTERRUPTED 60
515 ABNORMAL DREAMS 59
516 DEEP VEIN THROMBOSIS POSTOPERATIVE 59
517 EXPOSURE DURING PREGNANCY 59
518 SPONDYLITIS 59
519 THROAT TIGHTNESS 59
520 UPPER-AIRWAY COUGH SYNDROME 59
521 BASAL CELL CARCINOMA 58
522 BLOOD MAGNESIUM DECREASED 58
523 DELUSION 58
524 FAECES DISCOLOURED 58
525 HYPOAESTHESIA ORAL 58
526 INJECTION SITE RASH 58
527 LIGAMENT SPRAIN 58
528 PROCEDURAL PAIN 58
529 THYROID DISORDER 58
530 BLOOD COUNT ABNORMAL 57
531 ERUCTATION 57
532 FEBRILE NEUTROPENIA 57
533 INFUSION SITE SWELLING 57
534 INTERVERTEBRAL DISC DEGENERATION 57
535 NERVE INJURY 57
536 PRODUCT AVAILABILITY ISSUE 57
537 ANAPHYLACTIC REACTION 56
538 CHROMATURIA 56
539 GALLBLADDER DISORDER 56
540 INTERNATIONAL NORMALISED RATIO INCREASED 56
541 SENSORY DISTURBANCE 56
542 SKIN LACERATION 56
543 TENDONITIS 56
544 VAGINAL HAEMORRHAGE 56
545 HAEMATOMA 55
546 HYPERTONIC BLADDER 55
547 PERICARDIAL EFFUSION 55
548 THINKING ABNORMAL 55
549 TOOTHACHE 55
550 ANAL INCONTINENCE 54
551 BLOOD ALKALINE PHOSPHATASE INCREASED 54
552 LUPUS VULGARIS 54
553 PARAESTHESIA ORAL 54
554 PRURITUS GENERALISED 54
555 SKIN IRRITATION 54
556 THIRST 54
557 BLOOD URINE PRESENT 53
558 COORDINATION ABNORMAL 53
559 DEVICE OCCLUSION 53
560 DISABILITY 53
561 DRUG EFFECT DECREASED 53
562 HYPOKINESIA 53
563 IMMUNE SYSTEM DISORDER 53
564 MOUTH ULCERATION 53
565 OCULAR DISCOMFORT 53
566 ORAL CANDIDIASIS 53
567 SPINAL OSTEOARTHRITIS 53
568 TEMPERATURE INTOLERANCE 53
569 ABDOMINAL PAIN LOWER 52
570 ANHEDONIA 52
571 BACK INJURY 52
572 LIP SWELLING 52
573 PNEUMONITIS 52
574 POST PROCEDURAL COMPLICATION 52
575 PULMONARY HYPERTENSION 52
576 SKIN ABRASION 52
577 ABASIA 51
578 CORONARY ARTERY DISEASE 51
579 INCREASED APPETITE 51
580 MENTAL STATUS CHANGES 51
581 SERONEGATIVE ARTHRITIS 51
582 CHOKING 50
583 COLD SWEAT 50
584 CONJUNCTIVITIS 50
585 HOSPICE CARE 50
586 IMMUNODEFICIENCY 50
587 ORAL DISCOMFORT 50
588 SPINAL FUSION SURGERY 50
589 SPINAL OPERATION 50
590 TENDERNESS 50
591 TENDON RUPTURE 50
592 DECREASED ACTIVITY 49
593 DECREASED INTEREST 49
594 LEUKOCYTOSIS 49
595 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 49
596 TENDON PAIN 49
597 NEPHROGENIC ANAEMIA 48
598 ONYCHOCLASIS 48
599 BLOOD TEST ABNORMAL 47
600 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47
601 EAR DISCOMFORT 47
602 GLAUCOMA 47
603 MACULAR DEGENERATION 47
604 MUSCLE ATROPHY 47
605 OSTEOMYELITIS 47
606 PRODUCT STORAGE ERROR 47
607 RETINITIS 47
608 SPINAL PAIN 47
609 SUICIDE ATTEMPT 47
610 WRIST FRACTURE 47
611 X-RAY ABNORMAL 47
612 AGGRESSION 46
613 DRY THROAT 46
614 HAIR TEXTURE ABNORMAL 46
615 IMPAIRED QUALITY OF LIFE 46
616 INJECTION SITE URTICARIA 46
617 NODULE 46
618 PSYCHOTIC DISORDER 46
619 BEDRIDDEN 45
620 BLOOD BILIRUBIN INCREASED 45
621 EYE HAEMORRHAGE 45
622 GASTROINTESTINAL PAIN 45
623 IMPAIRED GASTRIC EMPTYING 45
624 LEUKOPENIA 45
625 PARANOIA 45
626 PHARYNGITIS STREPTOCOCCAL 45
627 QUALITY OF LIFE DECREASED 45
628 SARS-COV-2 TEST POSITIVE 45
629 ABSCESS 44
630 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 44
631 DERMATITIS 44
632 EXPIRED PRODUCT ADMINISTERED 44
633 HYPERLIPIDAEMIA 44
634 MUSCLE STRAIN 44
635 NAIL DISORDER 44
636 RASH PAPULAR 44
637 TOOTH ABSCESS 44
638 UPPER LIMB FRACTURE 44
639 ACTIVITIES OF DAILY LIVING IMPAIRED 43
640 CEREBRAL HAEMORRHAGE 43
641 EXPOSURE VIA SKIN CONTACT 43
642 FULL BLOOD COUNT ABNORMAL 43
643 HAEMATURIA 43
644 HUNGER 43
645 HYPERCALCAEMIA 43
646 SCAB 43
647 VITREOUS FLOATERS 43
648 BLOOD PRESSURE SYSTOLIC ABNORMAL 42
649 DRUG-INDUCED LIVER INJURY 42
650 EYE DISCHARGE 42
651 EYE INFECTION 42
652 IMPAIRED DRIVING ABILITY 42
653 INFUSION SITE HAEMORRHAGE 42
654 INITIAL INSOMNIA 42
655 MENISCUS INJURY 42
656 ORTHOSTATIC HYPOTENSION 42
657 PHARYNGEAL SWELLING 42
658 PSYCHOMOTOR HYPERACTIVITY 42
659 PULMONARY CONGESTION 42
660 UNRESPONSIVE TO STIMULI 42
661 VITAMIN D DECREASED 42
662 BLOOD TRIGLYCERIDES INCREASED 41
663 CONCUSSION 41
664 NEEDLE ISSUE 41
665 PERONEAL NERVE PALSY 41
666 PETECHIAE 41
667 RENAL INJURY 41
668 DENTAL CARIES 40
669 DEVICE RELATED INFECTION 40
670 MEDICATION ERROR 40
671 PAIN OF SKIN 40
672 PHOTOSENSITIVITY REACTION 40
673 ROSACEA 40
674 SKIN INFECTION 40
675 SLUGGISHNESS 40
676 SPINAL DISORDER 40
677 ACCIDENTAL OVERDOSE 39
678 BONE DENSITY DECREASED 39
679 BOWEL MOVEMENT IRREGULARITY 39
680 CYST 39
681 DEPRESSED LEVEL OF CONSCIOUSNESS 39
682 GINGIVAL BLEEDING 39
683 GINGIVAL PAIN 39
684 LIVER FUNCTION TEST ABNORMAL 39
685 NERVOUS SYSTEM DISORDER 39
686 PROSTATE CANCER 39
687 RASH GENERALISED 39
688 CARDIOMEGALY 38
689 EXERCISE TOLERANCE DECREASED 38
690 EXTRA DOSE ADMINISTERED 38
691 FOETAL EXPOSURE DURING PREGNANCY 38
692 KNEE OPERATION 38
693 LOCAL SWELLING 38
694 PALLOR 38
695 PERITONITIS 38
696 RESPIRATORY DISTRESS 38
697 RHABDOMYOLYSIS 38
698 SOMNAMBULISM 38
699 THERAPY CHANGE 38
700 ANGINA PECTORIS 37
701 ARTHROPOD BITE 37
702 EPILEPSY 37
703 ESSENTIAL HYPERTENSION 37
704 HYPERAESTHESIA 37
705 HYPOMAGNESAEMIA 37
706 INFUSION SITE DISCHARGE 37
707 IRON DEFICIENCY ANAEMIA 37
708 MITRAL VALVE INCOMPETENCE 37
709 NERVE COMPRESSION 37
710 SCAR 37
711 VENTRICULAR EXTRASYSTOLES 37
712 VISUAL ACUITY REDUCED 37
713 APHTHOUS ULCER 36
714 APPLICATION SITE ERYTHEMA 36
715 CHOLECYSTECTOMY 36
716 DECUBITUS ULCER 36
717 GASTROINTESTINAL INFECTION 36
718 GROIN PAIN 36
719 INTERNAL HAEMORRHAGE 36
720 MALIGNANT MELANOMA 36
721 MASS 36
722 METASTASES TO BONE 36
723 MONOPARESIS 36
724 POSTOPERATIVE WOUND INFECTION 36
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 36
726 PULMONARY ARTERIAL HYPERTENSION 36
727 SECRETION DISCHARGE 36
728 SEDATION 36
729 WHITE BLOOD CELL COUNT ABNORMAL 36
730 ADRENAL INSUFFICIENCY 35
731 APATHY 35
732 BLOOD CREATINE PHOSPHOKINASE INCREASED 35
733 BLOOD PRESSURE DIASTOLIC DECREASED 35
734 DEVICE DIFFICULT TO USE 35
735 DRUG EFFECT LESS THAN EXPECTED 35
736 HORDEOLUM 35
737 NEUTROPHIL COUNT INCREASED 35
738 POOR VENOUS ACCESS 35
739 PRODUCT ADMINISTRATION ERROR 35
740 RELAPSING-REMITTING MULTIPLE SCLEROSIS 35
741 VITAMIN B12 DECREASED 35
742 BLOOD CALCIUM DECREASED 34
743 COVID-19 PNEUMONIA 34
744 FACIAL PAIN 34
745 FAECES SOFT 34
746 FLANK PAIN 34
747 GAIT SPASTIC 34
748 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34
749 GASTRIC ULCER 34
750 HALLUCINATION, AUDITORY 34
751 PARANASAL SINUS DISCOMFORT 34
752 SCOLIOSIS 34
753 THERMAL BURN 34
754 TOOTH FRACTURE 34
755 ULCER HAEMORRHAGE 34
756 ANOSMIA 33
757 BLOOD GLUCOSE ABNORMAL 33
758 DEVICE BREAKAGE 33
759 DEVICE LEAKAGE 33
760 DRUG DEPENDENCE 33
761 EJECTION FRACTION DECREASED 33
762 GASTROENTERITIS 33
763 HEMIPARESIS 33
764 HEPATIC FAILURE 33
765 PLATELET COUNT ABNORMAL 33
766 SPLENOMEGALY 33
767 SUPRAVENTRICULAR TACHYCARDIA 33
768 TARDIVE DYSKINESIA 33
769 BLEPHAROSPASM 32
770 BLOOD THYROID STIMULATING HORMONE INCREASED 32
771 CORONARY ARTERY OCCLUSION 32
772 ELECTROLYTE IMBALANCE 32
773 FRUSTRATION TOLERANCE DECREASED 32
774 GENERALISED TONIC-CLONIC SEIZURE 32
775 HAIR COLOUR CHANGES 32
776 INFUSION SITE EXTRAVASATION 32
777 INTERSTITIAL LUNG DISEASE 32
778 MYELODYSPLASTIC SYNDROME 32
779 PARALYSIS 32
780 PELVIC PAIN 32
781 POST-TRAUMATIC STRESS DISORDER 32
782 PROTEINURIA 32
783 RENAL CYST 32
784 RENAL PAIN 32
785 SMALL INTESTINAL OBSTRUCTION 32
786 SQUAMOUS CELL CARCINOMA 32
787 ARTERIOSCLEROSIS CORONARY ARTERY 31
788 BLINDNESS UNILATERAL 31
789 BLOOD DISORDER 31
790 C-REACTIVE PROTEIN 31
791 COLON CANCER 31
792 COMPLICATION ASSOCIATED WITH DEVICE 31
793 ELECTROCARDIOGRAM QT PROLONGED 31
794 FOOD ALLERGY 31
795 GASTROINTESTINAL INFLAMMATION 31
796 GENERALISED OEDEMA 31
797 HEREDITARY ANGIOEDEMA 31
798 MAJOR DEPRESSION 31
799 PRODUCT DISTRIBUTION ISSUE 31
800 PULMONARY THROMBOSIS 31
801 SENSORY LOSS 31
802 UPPER GASTROINTESTINAL HAEMORRHAGE 31
803 UROSEPSIS 31
804 ATELECTASIS 30
805 BLOOD PRESSURE DIASTOLIC ABNORMAL 30
806 BREAST MASS 30
807 CARDIOVASCULAR DISORDER 30
808 CLOSTRIDIUM DIFFICILE COLITIS 30
809 ECONOMIC PROBLEM 30
810 ENCEPHALOPATHY 30
811 HAEMATEMESIS 30
812 LACERATION 30
813 LUNG NEOPLASM MALIGNANT 30
814 NEEDLE FATIGUE 30
815 OVARIAN CYST 30
816 PNEUMONIA BACTERIAL 30
817 POST PROCEDURAL INFECTION 30
818 PREMATURE BABY 30
819 SENSITIVE SKIN 30
820 URINE ABNORMALITY 30
821 ABNORMAL FAECES 29
822 BLOOD CALCIUM INCREASED 29
823 BONE LOSS 29
824 CARDIAC FLUTTER 29
825 DIABETES MELLITUS INADEQUATE CONTROL 29
826 EYELID PAIN 29
827 FLUID OVERLOAD 29
828 HAEMOGLOBIN INCREASED 29
829 INFUSION SITE PRURITUS 29
830 MADAROSIS 29
831 MUCOSAL INFLAMMATION 29
832 MUSCLE DISORDER 29
833 ON AND OFF PHENOMENON 29
834 RED CELL DISTRIBUTION WIDTH INCREASED 29
835 RHINITIS ALLERGIC 29
836 SCREAMING 29
837 URINE OUTPUT DECREASED 29
838 CONVULSION 28
839 CYTOPENIA 28
840 ENERGY INCREASED 28
841 FRACTURE 28
842 GASTROINTESTINAL ULCER 28
843 HEPATIC ENCEPHALOPATHY 28
844 HICCUPS 28
845 HYPERKERATOSIS 28
846 HYPERVOLAEMIA 28
847 HYSTERECTOMY 28
848 JAUNDICE 28
849 LUNG INFECTION 28
850 MALNUTRITION 28
851 MANIA 28
852 NEPHROPATHY 28
853 OESOPHAGITIS 28
854 PNEUMOTHORAX 28
855 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28
856 URINE ODOUR ABNORMAL 28
857 ANGIOEDEMA 27
858 APPETITE DISORDER 27
859 ARTERIOSCLEROSIS 27
860 ATRIAL FLUTTER 27
861 CARDIAC MURMUR 27
862 DECREASED IMMUNE RESPONSIVENESS 27
863 DIVERTICULUM 27
864 EYE INFLAMMATION 27
865 FEELING DRUNK 27
866 FOOD POISONING 27
867 IMMUNOSUPPRESSION 27
868 IRON DEFICIENCY 27
869 JOINT EFFUSION 27
870 LIVE BIRTH 27
871 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27
872 NYSTAGMUS 27
873 ORAL MUCOSAL BLISTERING 27
874 PANCREATITIS ACUTE 27
875 PELVIC FRACTURE 27
876 PRODUCT PRESCRIBING ISSUE 27
877 PROTEIN URINE PRESENT 27
878 SNORING 27
879 TOOTH LOSS 27
880 VASCULITIS 27
881 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27
882 ABORTION SPONTANEOUS 26
883 BENIGN PROSTATIC HYPERPLASIA 26
884 BRUXISM 26
885 COAGULOPATHY 26
886 DRUG ADMINISTRATION ERROR 26
887 FURUNCLE 26
888 HAEMORRHAGE INTRACRANIAL 26
889 HAIR GROWTH ABNORMAL 26
890 INABILITY TO AFFORD MEDICATION 26
891 INTENTIONAL OVERDOSE 26
892 INTESTINAL PERFORATION 26
893 LIBIDO DECREASED 26
894 LIGHT CHAIN ANALYSIS INCREASED 26
895 MUSCLE RIGIDITY 26
896 MYOSITIS 26
897 OROPHARYNGEAL DISCOMFORT 26
898 PHARYNGITIS 26
899 REHABILITATION THERAPY 26
900 SPINAL COLUMN STENOSIS 26
901 SPINAL COMPRESSION FRACTURE 26
902 SPINAL STENOSIS 26
903 SQUAMOUS CELL CARCINOMA OF SKIN 26
904 SYNOVIAL CYST 26
905 BREAST PAIN 25
906 CATAPLEXY 25
907 COMPRESSION FRACTURE 25
908 DIABETIC FOOT 25
909 DYSGRAPHIA 25
910 EMPHYSEMA 25
911 GLUCOSE TOLERANCE IMPAIRED 25
912 HYPERACUSIS 25
913 HYPERPARATHYROIDISM SECONDARY 25
914 MEAN CELL VOLUME INCREASED 25
915 ORAL DISORDER 25
916 PERIPHERAL VASCULAR DISORDER 25
917 POOR PERIPHERAL CIRCULATION 25
918 POST PROCEDURAL HAEMORRHAGE 25
919 PRODUCT TASTE ABNORMAL 25
920 RENAL FAILURE ACUTE 25
921 SINUS HEADACHE 25
922 SJOGREN^S SYNDROME 25
923 SUBDURAL HAEMATOMA 25
924 SUNBURN 25
925 TOXIC EPIDERMAL NECROLYSIS 25
926 TRIGGER FINGER 25
927 WOUND COMPLICATION 25
928 WRONG TECHNIQUE IN DRUG USAGE PROCESS 25
929 ABDOMINAL HERNIA 24
930 AFFECTIVE DISORDER 24
931 BLOOD LACTATE DEHYDROGENASE INCREASED 24
932 DYSMENORRHOEA 24
933 ELECTROCARDIOGRAM ABNORMAL 24
934 GASTROINTESTINAL SOUNDS ABNORMAL 24
935 GENERAL SYMPTOM 24
936 HYPOCALCAEMIA 24
937 HYPOPNOEA 24
938 INFUSION SITE REACTION 24
939 INGUINAL HERNIA 24
940 LYMPHOEDEMA 24
941 NEOPLASM 24
942 POLYURIA 24
943 PRODUCT DISPENSING ERROR 24
944 PRODUCT FORMULATION ISSUE 24
945 RASH VESICULAR 24
946 SEROTONIN SYNDROME 24
947 SINUS PAIN 24
948 SKIN REACTION 24
949 SKIN SWELLING 24
950 TRIGEMINAL NEURALGIA 24
951 TUMOUR MARKER INCREASED 24
952 VIRAL UPPER RESPIRATORY TRACT INFECTION 24
953 BLOOD ALBUMIN DECREASED 23
954 BLOOD CHLORIDE DECREASED 23
955 BLOOD SODIUM INCREASED 23
956 DEVICE FAILURE 23
957 EUPHORIC MOOD 23
958 FOREIGN BODY SENSATION IN EYES 23
959 HYPERTHYROIDISM 23
960 INCORRECT DRUG ADMINISTRATION RATE 23
961 MENSTRUATION IRREGULAR 23
962 MUSCLE FATIGUE 23
963 ONYCHOMADESIS 23
964 PREGNANCY 23
965 PRODUCT PHYSICAL ISSUE 23
966 RETINAL DETACHMENT 23
967 SPUTUM DISCOLOURED 23
968 TONGUE DISCOLOURATION 23
969 TRANSFUSION 23
970 WOUND HAEMORRHAGE 23
971 APPENDICITIS 22
972 APPLICATION SITE PAIN 22
973 BACTERAEMIA 22
974 BARRETT^S OESOPHAGUS 22
975 BIPOLAR DISORDER 22
976 CEREBRAL DISORDER 22
977 COELIAC DISEASE 22
978 DERMATITIS ACNEIFORM 22
979 DEVICE USE ERROR 22
980 DIALYSIS 22
981 DRUG TOLERANCE DECREASED 22
982 FACIAL PARALYSIS 22
983 HAIR DISORDER 22
984 INCORRECT PRODUCT ADMINISTRATION DURATION 22
985 MALABSORPTION 22
986 MELANOCYTIC NAEVUS 22
987 MENORRHAGIA 22
988 METABOLIC ACIDOSIS 22
989 MOUTH SWELLING 22
990 NASAL DRYNESS 22
991 NEUROLOGICAL SYMPTOM 22
992 OPTIC NEURITIS 22
993 PARANASAL SINUS HYPERSECRETION 22
994 PERIORBITAL SWELLING 22
995 PERSONALITY CHANGE 22
996 PLANTAR FASCIITIS 22
997 PRODUCT ADHESION ISSUE 22
998 PRODUCT PREPARATION ERROR 22
999 PYELONEPHRITIS 22